hemophilia Blood Cell Traits Linked to Individual Loci, Polygenic Contributors in International Studies Two new papers have identified thousands of genetic loci with ties to more than two-dozen blood cell traits in individuals from up to five ancestry groups. Asks for More Reuters reports that the Food and Drug Administration has rejected BioMarin's gene therapy for hemophilia A and has asked for longer-term data. A High Price A gene therapy for hemophilia could cost millions of dollars, NPR writes. New Hemophilia Treatment Data Spark Therapeutics reports new data on its investigational hemophilia A treatment that says it reduces bleeds, according to Stat News. Quickly, Quickly Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News. Oct 9, 2014 Alnylam Sees a Return to Big Indications amid Advances in Rare Diseases Premium Aug 7, 2014 Alnylam Hemophilia Drug Gets European Orphan Drug Status Premium Jan 23, 2014 Alnylam Begins Phase I Testing of Hemophilia Drug Premium Oct 31, 2013 Alnylam Files to Begin Phase I Trial of Hemophilia Drug Premium Oct 9, 2013 Hemophilia Genotyping Effort Funded by Biogen Idec Expanded Nationwide Premium Aug 22, 2013 Alnylam Receives Additional Orphan Drug Designation for Hemophilia Drug Premium Aug 15, 2013 Alnylam Execs Highlight Conjugate Delivery Tech as Lipid-Enabled TTR Drug Advances Premium Aug 15, 2013 Alnylam Receives Orphan Drug Designation for Hemophilia B Candidate Premium Jul 3, 2013 Alnylam Releases Positive Preclinical Data from Hemophilia Program Premium May 9, 2013 Alnylam to Release Phase II ATTR Data, Launch Expansion Trial in Coming Months Premium Jan 10, 2013 Alnylam Adds New Program to Pipeline as It Shelves Anemia Candidate Premium Dec 13, 2012 Alnylam Presents Preclinical Data from Hemophilia, Hemoglobinopathy Programs Premium Nov 14, 2012 Biogen Idec and Partners to Offer Free Genetic Testing to Hemophilia Patients to Advance Insights Premium Nov 8, 2012 Biogen Idec, NHF Launch Hemophilia Genotype Testing Initiative Nov 8, 2012 Alnylam ATTR Program on Track as Company Explores Subcutaneous Delivery for Cholesterol Drug Premium Aug 9, 2012 Reporting Positive Data on Conjugate Delivery Tech, Alnylam Preps IND for Subcutaneous ATTR Therapy Premium Jul 12, 2012 Alnylam Selects Hemophilia Candidate, Releases Preclinical Data Premium Feb 16, 2012 Alnylam Provides Timelines for Drug Programs, Offers No Formal Guidance on Partnerships Premium Jan 12, 2012 Alnylam Focuses on Two Lead Programs, Won't Advance Others without Partners Premium Sep 16, 2011 Stanford-Led Team Demonstrates Utility of Ethnicity-Specific Reference for Interpreting Genome Data Load More Breaking News GenXys, Helix Partner to Provide Clinical Decision Support for PGx Testing Persephone Biosciences, Janssen Biotech Ink Biomarker Discovery Agreement Personal Genome Diagnostics, Cleveland Clinic Join Forces to Advance Liquid Biopsy PhenoTips Raises C$2.5M in Seed Funding Fauna Bio Raises $9M in Seed Money Phosphorus Wins Conditional New York State Approval for GeneCompass Consumer Test The Scan Two J&J Doses Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports. Pfizer-BioNTech Vaccine Response in Kids The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post. Chicken Changes to Prevent Disease The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics. PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.